The Peptide Boom Meets FDA Reality

Peptides have quickly become one of the fastest-growing and most talked-about segments of the healthcare market, fueling weight loss clinics, performance medicine, and a $740B longevity market. But as demand accelerates, the FDA is moving decisively to tighten the gap between how these products are marketed and how they are regulated. What was once a loosely defined space is now under direct and increasing scrutiny.... By: Gardner Law